StemCells Incorporated

Type: Company
Name: StemCells Incorporated
First reported Sep 17 2014 - Updated Sep 17 2014 - 1 reports

Five Questions With: Dr. Lars Wahlberg

Lars Wahlberg is president and CEO of NsGene, a life sciences company working on innovative brain-repair therapy that treats diseases such as Parkinson’s. An award recipient in PBN’s 2014 Fastest-Growing & Innovative Companies program, NsGene was founded ... [Published Providence Business News - Sep 17 2014]
First reported Sep 11 2014 - Updated Sep 11 2014 - 1 reports

CIRM Tightens 'Revolving Door' Policy for Employees Seeking Jobs at Institute-Funded Companies

On Thursday, the California Institute for Regenerative Medicine tightened its "revolving door" policy to avoid the appearance of conflicts of interest. The new policy requires employees to contact CIRM's general counsel if they begin discussions with ... [Published California Healthline - Sep 11 2014]
First reported Aug 26 2014 - Updated Aug 27 2014 - 1 reports

StemCells Q2 net loss increases

StemCells, Inc., a developer of cell-based therapeutics, has reported that net loss for the second quarter ended June 30, 2014 was $12.11 million, or $0.22 loss per share, compared to a net loss of $5.87 million, or $0.15 loss per share, for the same ... [Published Individual.com - Aug 26 2014]
First reported Aug 15 2014 - Updated Aug 15 2014 - 1 reports

Video: Stemcells’ Promising News on Spinal Cord Injury, AMD Therapies

Martin McGlynn, CEO of Stemcells Inc., disclosed to BioWorld fascinating data from a phase I /II clinical trial of human neural stem cells to treat chronic spinal cord injury, including multi-segmental gains in function and a return of function in the ... [Published BioPortfolio - Aug 15 2014]
First reported Aug 15 2014 - Updated Aug 15 2014 - 2 reports

StemCells Inc ShortTerm Noise Creates Another Buying Opportunity

By JMY Investments :I dialed into the StemCells, Inc's (NASDAQ: STEM ) quarterly conference call expecting to hear from a company on its heels from recent allegations of covering up shoddy manufacturing practices by a former employee who is suing the ... [Published BioPortfolio - Aug 15 2014]
First reported Aug 12 2014 - Updated Aug 13 2014 - 3 reports

StemCells' (STEM) CEO Martin McGlynn on Q2 2014 Results - Earnings Call Transcript

OperatorGood day ladies and gentleman and welcome to the StemCells’ Second Quarter 2014 Earnings Conference Call. At this time, all participants are in a listen-only mode. Later we will conduct a question-and-answer session and instructions will be given ... [Published Seeking Alpha - Aug 13 2014]
First reported Aug 12 2014 - Updated Aug 12 2014 - 1 reports

Stemcells (STEM) Releases Quarterly Earnings Results

Stemcells (NASDAQ:STEM) issued its quarterly earnings data on Tuesday. The company reported ($0.22) earnings per share for the quarter, missing the analysts’ consensus estimate of ($0.14) by $0.08, reports. A number of research firms have recently commented ... [Published American Banking News - Forex - Aug 12 2014]
First reported Jul 26 2014 - Updated Jul 26 2014 - 1 reports

California stem cell agency head takes stand on 'personal ethics'

The California Institute for Regenerative Medicine has continued in damage-control mode since the state agency’s former president, Alan Trounson, joined the board of directors at StemCells Inc. this month, just seven days after leaving the agency. ... [Published Greenspace - Jul 26 2014]
First reported Jul 11 2014 - Updated Jul 11 2014 - 2 reports

California stem cell agency to review dealings with StemCells Inc.

California’s stem cell agency announced Wednesday it was taking steps to deal with a “risk of conflict of interest” two days after its former president took a position with a company that the state agency had been funding. ... [Published Greenspace - Jul 11 2014]
First reported Jul 08 2014 - Updated Jul 09 2014 - 1 reports

Ex-president of California stem cell agency now on board of StemCells Inc.

StemCells Inc.’s board of directors now includes the former president of the California stem cell agency that gave the company $19.4 million in research funding. StemCells Inc., a Newark company developing stem cell-based therapies, said Monday Dr. Alan ... [Published Tech Chronicles - Jul 08 2014]
First reported Jun 20 2014 - Updated Jun 20 2014 - 1 reports

Why StemCells (STEM) Stock Hit Another One-Year High Today

NEW YORK (TheStreet) -- StemCells  surged to another 52-week high of $2.34 on Friday, as the company continued to rise on the strength of its positive interim results from a Phase I/II clinical trial of its proprietary HuCNS-SC human neural stem cell ... [Published The Street Latest - Jun 20 2014]
First reported Jun 19 2014 - Updated Jun 19 2014 - 1 reports

Why StemCells (STEM) Hit a One-Year High Today

NEW YORK (TheStreet) -- StemCells  surged to a 52-week high of $2 on Thursday after the company reported positive interim results from a Phase I/II clinical trial of its proprietary HuCNS-SC human neural stem cell platform in dry age-related macular ... [Published The Street Latest - Jun 19 2014]

Quotes

"FIG. 3 depicts data from a study in which the average amount of various proteins secreted into the medium was measured after four days of culture."
...The new policy requires employees to contact CIRM's general counsel if they begin discussions with a "prospective employer that has received or is currently applying for CIRM funding." The move comes after the agency's former president was named to the board of directors of StemCells Inc., which was awarded $19 million by CIRM...
...a need which we continue to believe may be addressed with Dex-IN," said Gerri Henwood, Recro Pharma's President and Chief Executive Officer. "Observations from an interim analysis of the REC-13-012 trial, however, suggest that the current study design will not allow us to reach statistical significance for single agent Dex-IN in a bunionectomy pain model starting on Post Op Day 0."

More Content

All (51) | News (26) | Reports (0) | Blogs (6) | Audio/Video (0) | Fact Sheets (1) | Press Releases (18)
sort by: Date | Relevance
Patent Application Titled "Encapsulated Kidney ... [Published HispanicBusiness.com - Sep 17 2014]
Five Questions With: Dr. Lars Wahlberg [Published Providence Business News - Sep 17 2014]
CIRM Tightens 'Revolving Door' Policy for Emplo... [Published California Healthline - Sep 11 2014]
Global Age-Related Macular Degeneration (AMD) M... [Published Ask.com - Sep 11 2014]
Reco Pharma Says Trial Study Not Seen Reaching ... [Published BioMedReports - Sep 05 2014]
StemCells, Inc. to Participate at the 16th Annu... [Published GlobeNewswire: Acquisitions News - Sep 04 2014]
StemCells Q2 net loss increases [Published Individual.com - Aug 26 2014]
Stem cells: the potential, the reality and the ... [Published Medianet - Aug 25 2014]
Video: Stemcells’ Promising News on Spinal Cord... [Published BioPortfolio - Aug 15 2014]
StemCells Inc ShortTerm Noise Creates Another B... [Published BioPortfolio - Aug 15 2014]
StemCells, Inc: Short-Term Noise Creates Anothe... [Published Seeking Alpha - Aug 15 2014]
EPZM For The Long Haul, RVNC Awaits Facelift, E... [Published RTTNews.com - Aug 13 2014]
Pfizer Issues Top-Line Results from Potherpetic... [Published BioMedReports - Aug 13 2014]
StemCells' (STEM) CEO Martin McGlynn on Q2 2014... [Published Seeking Alpha - Aug 13 2014]
STEMCELLS INC - 10-Q - MANAGEMENT'S DISCUSSION ... [Published Wall Street Business Network - Aug 13 2014]
Stemcells (STEM) Releases Quarterly Earnings Re... [Published American Banking News - Forex - Aug 12 2014]
StemCells, Inc. Reports Second Quarter 2014 Fin... [Published Virtual Strategy Magazine - Aug 12 2014]
StemCells, Inc. Reports Second Quarter 2014 Fin... [Published GlobeNewswire: Advertising News - Aug 12 2014]
StemCells, Inc. Reports Second Quarter 2014 Fin... [Published Industrial Info Financials - Aug 12 2014]
Technical Data on Biotech Stocks -- Arrowhead R... [Published Financial Services - Aug 04 2014]
California stem cell agency head takes stand on... [Published Greenspace - Jul 26 2014]
StemCells, Inc. Announces Closing of $20 Millio... [Published GlobeNewswire: Acquisitions News - Jul 18 2014]
Why StemCells (STEM) Stock Is Down Today [Published The Street Latest - Jul 15 2014]
StemCells, Inc. Announces Proposed $20 Million ... [Published GlobeNewswire: Advertising News - Jul 15 2014]
California stem cell agency to review dealings ... [Published Greenspace - Jul 11 2014]
California stem cell agency to review dealings ... [Published Top of the Ticket - Jul 11 2014]
Stem cell agency outlines steps to prevent “pot... [Published Tech Chronicles - Jul 09 2014]
Ex-president of California stem cell agency now... [Published Tech Chronicles - Jul 08 2014]
StemCells, Inc. Appoints Dr. Alan Trounson to B... [Published GlobeNewswire: Advertising News - Jul 07 2014]
Agreements, NDA Submissions, FDA Approvals, Enr... [Published Financial Services - Jul 07 2014]
1 2
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
California stem cell agency head takes stand on... [Published Greenspace - Jul 26 2014]
The California Institute for Regenerative Medicine has continued in damage-control mode since the state agency’s former president, Alan Trounson, joined the board of directors at StemCells Inc. this month, just seven days after leaving the agency. ...
California stem cell agency to review dealings ... [Published Greenspace - Jul 11 2014]
California’s stem cell agency announced Wednesday it was taking steps to deal with a “risk of conflict of interest” two days after its former president took a position with a company that the state agency had been funding. ...
California stem cell agency to review dealings ... [Published Top of the Ticket - Jul 11 2014]
California’s stem cell agency announced Wednesday it was taking steps to deal with a “risk of conflict of interest” two days after its former president took a position with a company that the state agency had been funding. ...
Stem cell agency outlines steps to prevent “pot... [Published Tech Chronicles - Jul 09 2014]
Two days after the ex-president of California’s stem cell agency became a board director at a company that is receiving funding from the agency, the agency said Wednesday it is taking steps to “mitigate a potential conflict of interest.” Earlier this ...
Ex-president of California stem cell agency now... [Published Tech Chronicles - Jul 08 2014]
StemCells Inc.’s board of directors now includes the former president of the California stem cell agency that gave the company $19.4 million in research funding. StemCells Inc., a Newark company developing stem cell-based therapies, said Monday Dr. Alan ...
1 2

Press Releases

sort by: Date | Relevance
StemCells, Inc. to Participate at the 16th Annu... [Published GlobeNewswire: Acquisitions News - Sep 04 2014]
StemCells, Inc. Reports Second Quarter 2014 Fin... [Published GlobeNewswire: Advertising News - Aug 12 2014]
Technical Data on Biotech Stocks -- Arrowhead R... [Published Financial Services - Aug 04 2014]
StemCells, Inc. Announces Closing of $20 Millio... [Published GlobeNewswire: Acquisitions News - Jul 18 2014]
StemCells, Inc. Announces Proposed $20 Million ... [Published GlobeNewswire: Advertising News - Jul 15 2014]
1 2 3 4
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.